Year: 2019

REDWOOD CITY, Calif., Dec. 11, 2019 (GLOBE NEWSWIRE) — Despite longstanding medical guidelines recommending biomarker testing for all patients with metastatic colon cancer, a new study published in JCO Precision Oncology shows that only 40 percent of patients are tested according to guidelines.1 These findings are consistent with the rates seen in late-stage lung cancer, where clinical adoption of genomic profiling remains below the recommended standard-of-care guidelines.2 The result is that many patients are potentially being treated with less effective drugs, some having serious side-effects; while others are not being offered highly effective personalized treatment options. The multi-center retrospective study also found that certain subgroups of patients were less likely to be tested than others. Suboptimal genotyping occurred...

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATESTORONTO, Dec. 11, 2019 (GLOBE NEWSWIRE) — DREAM INDUSTRIAL REIT (DIR.UN-TSX) (“Dream Industrial REIT” or the “Trust”) announced today the closing of its previously announced equity offering of units of the Trust (“Units”) at a price of $13.45 per Unit (the “Public Offering”). The syndicate of underwriters, led by TD Securities Inc., elected to exercise its over-allotment option in full, resulting in a total of 12,834,000 Units being issued today for total gross proceeds of $172,617,300.As previously announced, the Trust will also sell an aggregate of 325,000 Units to Michael Cooper and Brian Pauls on a non-brokered private placement basis at a price of $13.45 per Unit (the “Private Placements”). The Private Placements are expected to be completed...

A major expansion of RigNet’s AVI to meet customers’ growing expectationsAgnostic to any video equipment or video feed – analog and digitalReal-time situational awareness analytics for automated remote monitoringLow bandwidth use over satellite networks, regardless of number of video streamsHOUSTON, Dec. 11, 2019 (GLOBE NEWSWIRE) — RigNet, Inc. (NASDAQ: RNET), the leading provider of ultra-secure, intelligent networking solutions, today launched a major expansion of its Adaptive Video Intelligence (AVI) suite called AVI LIVE. The market’s leading product for bandwidth-optimized secure video streams, now has a complete content management system and trigger- based workflows to significantly reduce requirements for “eyes-on-glass” monitoring. The completely redesigned user interface improves the viewing experience while accessing multiple...

VANCOUVER, British Columbia, Dec. 11, 2019 (GLOBE NEWSWIRE) — Novelion Therapeutics Inc. (Ticker: NVLNF) (“Novelion” or the “Company”) today announced that a hearing date has not yet been scheduled for consideration of the Company’s application materials, filed on November 18, 2019 with the Supreme Court of British Columbia (the “Court”), relating to Court orders sought by the Company in connection with the Company’s voluntary liquidation and dissolution (the “Liquidation”).  As previously announced, the Company expects that such hearing date, once assigned, will also serve as the effective date of commencement of the Liquidation (the “Effective Date”).  The Company intends to publicly announce the date of the hearing (and related Effective Date) as promptly as practicable after such date is received.Cautionary Information Regarding...

COLORADO SPRINGS, Dec. 11, 2019 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Gold Resource Corporation (NYSE American: GORO) (the “Company”) today announced the expansion of its Mirador Mine with fifteen (15) exploration drill hole results from its 2019 Alta Gracia projects drill program located at its Oaxaca Mining Unit, Mexico.  Highlights include 3.72 meters grading 1.44 grams per tonne (g/t) gold and 990 g/t silver, including 1.00 meter grading 2.84 g/t gold and 2,610 g/t silver in a step down hole to known mineralization.  Gold Resource Corporation is a gold and silver producer, developer and explorer with operations in Oaxaca, Mexico and Nevada, USA.  The Company has returned $112 million to its shareholders in monthly dividends since commercial production commenced July 1, 2010 and offers its shareholders the option to convert...

Resumé

HOUSTON, Dec. 11, 2019 (GLOBE NEWSWIRE) — Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers, today announced that The University of Texas MD Anderson Cancer Center exercised its option to license Bellicum’s CaspaCIDe® safety switch technology.Under terms of the original license agreement, MD Anderson’s decision to exercise the option entitled Bellicum to receive an upfront payment of $5 million, to be recognized in the fourth quarter 2019 financial results, and undisclosed future milestone payments and royalties on sales. The license agreement with Bellicum specifically covers use of the CaspaCIDe safety switch in MD Anderson’s CD19-directed chimeric antigen receptor natural killer (CAR NK) cell construct.“We are excited that MD Anderson recognizes the utility...

TORONTO, Dec. 11, 2019 (GLOBE NEWSWIRE) — CB2 Insights (CSE:CBII; OTCQB: CBIIF) (“CB2” or the “Company”), a leading data-driven company focused on bringing real-world evidence-driven from the point-26of-care to the medical cannabis community, announces a warrant exercise incentive program (the “Program”) which has been implemented to encourage the exercise of the Company’s outstanding warrants.  The Warrants are exercisable at a price of $0.09 per Common Share starting December 11, 2019 until December 26, 2019 (the “Early Exercise Period”).  The Company has received confirmation that shareholders Merida Capital, Phyto Partners, and other supportive institutional shareholders intend to support the Program.The Program has been created to encourage the early exercise of only those outstanding warrants with an exercise price between...

FREMONT, Calif., Dec. 11, 2019 (GLOBE NEWSWIRE) — Aehr Test Systems (NASDAQ: AEHR), a worldwide supplier of semiconductor test and reliability qualification equipment, today announced that Gayn Erickson, President and CEO, is scheduled to participate in the 8th Annual NYC Investor Summit 2019, taking place December 17, 2019 at the Parker New York Hotel in New York City.“We look forward to discussing the unique capabilities of our full family of FOX-P™ wafer-level and singulated die test and burn-in systems at the NYC Investor Summit,” said Mr. Erickson. “The significant market opportunities for our solutions include data storage, multiple devices related to the worldwide 5G build-out, chip-to-chip communication, sensors for electric vehicles and other transportation, and the silicon photonics and photonics sensors markets. We believe...